MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

Search

Orthofix International NV

Lezárt

SzektorEgészségügy

15.09 -1.57

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

15.04

Maximum

15.31

Fő mutatók

By Trading Economics

Bevétel

-8.7M

-23M

Értékesítés

2.5M

206M

Egy részvényre jutó nyereség

0.198

Profit margin

-11.085

Munkavállalók

1,616

EBITDA

-11M

-3.1M

Ajánlások

By TipRanks

Ajánlások

Erős vétel

12 hónapos előrejelzés

+39.14% upside

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-21M

613M

Előző nyitás

16.66

Előző zárás

15.09

Hangulat hírek alapján

By Acuity

50%

50%

157 / 374 Rangsor szerint Healthcare

Technikai pontszám

By Trading Central

Bizalom

Weak Bearish Evidence

Orthofix International NV Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2025. dec. 31. 22:20 UTC

Fő piaci mozgatók

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

2025. dec. 31. 17:31 UTC

Fő piaci mozgatók

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

2025. dec. 31. 16:30 UTC

Fő piaci mozgatók

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

2025. dec. 31. 15:19 UTC

Fő piaci mozgatók

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

2025. dec. 31. 15:17 UTC

Fő piaci mozgatók

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

2025. dec. 31. 14:37 UTC

Fő piaci mozgatók

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

2025. dec. 31. 21:50 UTC

Piaci beszéd

Basic Materials Roundup: Market Talk

2025. dec. 31. 21:13 UTC

Felvásárlások, összeolvadások, átvételek

10 People to Watch in Wealth Management in 2026 -- Barrons.com

2025. dec. 31. 20:40 UTC

Piaci beszéd

Dollar Posting Its Worst Year Since 2017 -- Market Talk

2025. dec. 31. 20:22 UTC

Piaci beszéd

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

2025. dec. 31. 19:50 UTC

Piaci beszéd

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

2025. dec. 31. 19:31 UTC

Piaci beszéd

Precious Metals Cap Off Record Runs -- Market Talk

2025. dec. 31. 18:50 UTC

Piaci beszéd

Global Equities Roundup: Market Talk

2025. dec. 31. 18:50 UTC

Piaci beszéd

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

2025. dec. 31. 17:17 UTC

Piaci beszéd

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

2025. dec. 31. 17:16 UTC

Fő piaci mozgatók

OwlTing Climbs on Launch of $10M Stock-Buyback Program

2025. dec. 31. 17:15 UTC

Piaci beszéd

Global Commodities Roundup: Market Talk

2025. dec. 31. 17:00 UTC

Felvásárlások, összeolvadások, átvételek

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

2025. dec. 31. 15:57 UTC

Felvásárlások, összeolvadások, átvételek

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

2025. dec. 31. 15:54 UTC

Piaci beszéd

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

2025. dec. 31. 15:02 UTC

Fő piaci mozgatók

Nike Shares Rise After CEO Hill Buys $1M of Shares

2025. dec. 31. 14:40 UTC

Felvásárlások, összeolvadások, átvételek

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

2025. dec. 31. 14:20 UTC

Piaci beszéd

Crude Futures On Track to End the Year With Losses -- Market Talk

2025. dec. 31. 13:46 UTC

Piaci beszéd

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

2025. dec. 31. 13:01 UTC

Eredményjelentés
Felvásárlások, összeolvadások, átvételek

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

2025. dec. 31. 11:10 UTC

Piaci beszéd

Copper Remains in Touching Distance of Record Highs -- Market Talk

2025. dec. 31. 10:46 UTC

Piaci beszéd

Euro on Track For Strong Annual Performance -- Market Talk

2025. dec. 31. 10:25 UTC

Piaci beszéd

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

2025. dec. 31. 10:23 UTC

Piaci beszéd

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

2025. dec. 31. 09:33 UTC

Piaci beszéd

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Társak összehasonlítása

Árváltozás

Orthofix International NV Előrejelzés

Célár

By TipRanks

39.14% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 21.33 USD  39.14%

Magas 24 USD

Alacsony 18 USD

3 Wall Street elemző 12 hónapos célárain alapulva a(z)Orthofix International NV termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

3 ratings

3

Vétel

0

Tartás

0

Eladás

Technikai pontszám

By Trading Central

10.4 / 12.1Támogatás & ellenállás

Rövid táv

Weak Bearish Evidence

Középtáv

Bearish Evidence

Hosszú táv

Bearish Evidence

Hangulat

By Acuity

157 / 374 Rangsor szerint Egészségügy

Hangulat hírek alapján

Neutral

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Orthofix International NV

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
help-icon Live chat